BHSC NOVEMBER NEWSLETTER

November 30, 2021

Dear subscriber,

December is upon us (Happy Thanksgiving to our US community!), and our R+D and Business Development/Marketing teams are pushing hard to hit our major 2021 Strategic Milestones. As we ramp up our external messaging in our Nutraceutical and Cannabis verticals, you will see more Bioharvest news in the media, but we will also continue to summarize our corporate and marketing highlights in our regular newsletter.

As we continue to build BioHarvest Sciences into a commercial machine, our followers can expect to see multiple major announcements, so stay tuned!

BHSC November News Releases

Nov 22, 2021 – Our new 20 Ton facility has formally obtained GMP certification from Israel’s Ministry of Health! VINIA® production will transfer to the new facility, which gives us the capacity to supply multiple global markets with over 20 tons/year of VINIA® as well as the other polyphenol-based products in BioHarvest’s innovation pipeline. In an interview with Proactive Investors, CEO Ilan Sobel commented “”We now have the critical oxygen that will allow us to grow based on demand and not be constrained based on supply.”
BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY OBTAINS THE GMP (GOOD MANUFACTURING PRACTICES) CERTIFICATION FROM THE ISRAELI MINISTRY OF HEALTH – Bioharvest

Nov 15, 2021 – We announced that our research has provided more support for the anti-oxidation structure/function claims for VINIA®. As stated by Yochi Hagay, BioHarvest CTO, “Cholesterol damages the cardiovascular functioning when it gets oxidized. The unique composition of VINIA® (that includes a complex of polyphenols with Piceid resveratrol) reduces the oxidation of the lipids as well as improves blood flow. 
NEW RESEARCH ANALYSIS SHOWS VINIA® REDUCES OXIDATION OF LDL-CHOLESTEROL TO SUPPORT CARDIOVASCULAR IMPROVED FUNCTIONING – Bioharvest

Senior BioTech Executives join the BioHarvest Team

We have proudly announced the addition of two impressive global executives, both of whom have grown life-science based BioTech businesses into major global brands. Adding these highly qualified executives will help us achieve our BioTech Vision for the company:

Steven Lehrer – Mr. Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D.
BIOHARVEST SCIENCES INC. APPOINTS STEVEN LEHRER TO ITS BOARD OF ADVISORS – Bioharvest

David Tsur – During his career, Mr. Tsur has been responsible for generating sales of more than $1 billion (USD) for companies operating in more than 20 countries. He has also built multiple strategic relationships with U.S. and European companies while leading these companies through the innovation processes.
BIOHARVEST SCIENCES INC. ANNOUNCES APPOINTMENT OF DAVID TSUR TO BOARD OF DIRECTORS – Bioharvest

BHSC Media Coverage

    

Marijuana Venture Magazine thought Biofarming “sounded like science fiction”, so they interviewed Ilan and are now featuring that interview across 4 pages in their new December version. This cannabis industry magazine is available on newsstands, but the digital version is available for purchase. For a free copy of the article, contact justin@bioharvest.com.

 

 

Extraction Magazine interviewed Ilan Sobel as part of their “Voices of Disruption” series, titled “Sustainably Biofarming Cannabinoids”. Read article

 

 

 

 

Weed World posted an in-depth article in the “Research and Development” section of Issue 153, titled “The Reservoir Revolution.” For a free copy of the article, contact justin@bioharvest.comSubscription article

 

 

Proactive Investors interviewed Ilan Sobel on the importance of the new 20 ton VINIA facility coming online to supply global growth.

 

 

 

BioHarvest Sciences factory receives GMP certification from Israeli Ministry of Health – YouTube

 

Upcoming Conferences
BioHarvest is pleased to be a sponsor of the upcoming Global Cannabis Intelligence Summit Dec 7-9, and Ilan will be presenting. We will share his presentation with the BioHarvest community following the summit.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This Thanksgiving season marked the first “Black Friday” opportunity for our VINIA® marketing team. We are so thankful for the VINIA® support and product advocacy that we have received from our BioHarvest community – thank you. If you know someone who would like to take advantage of our Black Friday 25% off special, please feel free to forward them the code: BLK25. This promotion runs to midnight, December 1.
To keep current on all BioHarvest content, we encourage you to follow us on TwitterFacebook, or LinkedIn. Thank you for your interest in BioHarvest Sciences, and please keep sharing your feedback. If you have any questions, please contact justin@bioharvest.com.

 

 

BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:

Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Email: dave@bioharvest.com

 

Forward-Looking Statements 

Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that strong sales metrics experienced to date will result in future demand or that proposed additional marketing expenditures will result in increased sales. Markets for nutraceuticals are unpredictable and subject to changes in consumer tastes and trends as well as economic factors beyond our control.  Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance, and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. There is no assurance that the Company sales revenue for 2022 will reach USD 5 to 7 million and there is no assurance that the Company cash flow breaking point will be achieved in 2023. There is no assurance of commercial availability of our Cannabis product in 2022 or that the Company achieves the conversion of the two tons VINIA® facility to Cannabis production in 2022. These things are subject to construction and approval delays and uncertainties that may be beyond the control of BioHarvest. Projected sales of Cannabis will require the Company to obtain production and/or export licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. 

Readers are cautioned that revenue alone do not give an accurate picture of the financial position of the Company and should be read in the context of the Company’s annual and quarterly financial statements.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.